Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Operating Expenses | 11,180 | 13,370 | 12,400 | 12,870 | 10,510 |
| Operating Income | -11,180 | -13,370 | -12,400 | -12,870 | -10,510 |
| Interest Expense | 0 | -1,010 | 320 | 330 | 360 |
| Other Income | -1,770 | -1,590 | 490 | 670 | 1,020 |
| Pre-tax Income | -12,950 | -13,950 | -12,230 | -12,530 | -9,850 |
| Net Income Continuous | -12,950 | -13,942 | -12,237 | -12,531 | -9,855 |
| Net Income | $-12,950 | $-13,942 | $-12,237 | $-12,531 | $-9,855 |
| EPS Basic Total Ops | -15.20 | -16.40 | -14.40 | -14.40 | -11.60 |
| EPS Basic Continuous Ops | -14.93 | -16.08 | -14.11 | -14.45 | -11.37 |
| EPS Diluted Total Ops | -15.20 | -16.40 | -14.40 | -14.40 | -11.60 |
| EPS Diluted Continuous Ops | -14.93 | -16.08 | -14.11 | -14.45 | -11.37 |
| EBITDA(a) | $-10,310 | $-12,610 | $-11,890 | $-12,310 | $-9,950 |